Free Trial

COSCIENS Biopharma (CSCI) SEC Filings & 10K Form

COSCIENS Biopharma logo
$2.90 +0.08 (+2.80%)
Closing price 03:50 PM Eastern
Extended Trading
$2.92 +0.02 (+0.69%)
As of 06:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent COSCIENS Biopharma SEC Filings

DateFilerForm TypeView
03/13/2025
2:24 PM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2024
6:45 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
5:05 PM
COSCIENS Biopharma Inc. (Subject)
COSCIENS Biopharma (Subject)
Goodwood Inc. (Filed by)
Form SCHEDULE 13D/A
10/08/2024
6:30 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
4:29 PM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
6:30 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
1:04 PM
COSCIENS Biopharma Inc. (Subject)
COSCIENS Biopharma (Subject)
Goodwood Inc. (Filed by)
Form SC 13D
08/27/2024
6:30 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2024
7:05 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2024
7:05 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
2:36 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2024
8:20 AM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2024
12:31 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2024
12:46 PM
Aeterna Zentaris Inc. (Subject)
COSCIENS Biopharma (Subject)
Goodwood Inc. (Filed by)
Form SC 13G
06/04/2024
11:15 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
06/04/2024
11:15 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
06/04/2024
11:15 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
05/30/2024
8:55 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form POS AM
05/30/2024
8:56 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form POS AM
05/30/2024
8:56 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form POS AM
05/30/2024
8:58 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/29/2024
8:31 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K/A
05/17/2024
7:00 AM
Aeterna Zentaris Inc. (Subject)
COSCIENS Biopharma (Subject)
Form FWP
05/17/2024
7:00 AM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
11:15 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
05/01/2024
3:51 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CSCI) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners